ALT-836

anti-tissue factor antibody · Altor BioScience

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALT-836, covering 2015-04-10 to 2016-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors [Phase 1]